Parallax Volatility Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Parallax Volatility Advisers’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,900	Closed	-$914K	–	2625
2023 Q3	$914K	Sell	7,900 -76,800	-91%	-$8.25M	﹤0.01%	1396
2023 Q2	$8.71M	Buy	84,700 +84,600	+84,600%	+$8.93M	0.02%	583
2023 Q1	$10.9K	Sell	100 -556,400	-100%	-$61.5M	﹤0.01%	2387
2022 Q4	$63.3M	Buy	556,500 +108,900	+24%	+$9.05M	0.1%	228
2022 Q3	$27.7M	Buy	447,600 +87,500	+24%	+$6.11M	0.04%	433
2022 Q2	$28.7M	Buy	+360,100	New	+$34.1M	0.03%	394
2021 Q4	–	Sell	-45,600	Closed	-$5M	–	2498
2021 Q3	$5M	Buy	+45,600	New	+$4.73M	﹤0.01%	835
2021 Q1	–	Sell	-176,400	Closed	-$12.9M	–	2376
2020 Q4	$12.9M	Buy	176,400 +151,400	+606%	+$11.3M	0.01%	648
2020 Q3	$1.94M	Buy	+25,000	New	+$1.72M	﹤0.01%	1720
2019 Q2	–	Sell	-50,000	Closed	-$1.32M	–	4209
2019 Q1	$1.32M	Buy	50,000 +46,900	+1,513%	+$1.11M	﹤0.01%	1151
2018 Q4	$61K	Buy	+3,100	New	+$60.8K	﹤0.01%	2065
2018 Q1	–	Sell	-100,000	Closed	-$1.46M	–	5113
2017 Q4	$1.46M	Hold	100,000	–	–	﹤0.01%	1039
2017 Q3	$1.27M	Buy	+100,000	New	+$1.27M	﹤0.01%	996
2016 Q1	–	Sell	-115,000	Closed	-$2.49M	–	4128
2015 Q4	$2.49M	Buy	115,000 +65,000	+130%	+$1.27M	0.01%	935
2015 Q3	$991K	Buy	+50,000	New	+$1.58M	﹤0.01%	1292

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parallax Volatility Advisers's HZNP Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 18,019 shares — an estimated $2.08M sold.

Parallax Volatility Advisers first reported a position in HZNP in Q3 2015 and held it in 14 quarters. The position peaked at $2.08M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Parallax Volatility Advisers reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 18,019 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.08M.
Parallax Volatility Advisers first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 14 quarters.
Parallax Volatility Advisers's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.08M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.